LADFX
Price
$26.85
Change
-$0.21 (-0.78%)
Updated
Sep 25 closing price
Net Assets
2.07B
NRGSX
Price
$63.00
Change
-$0.38 (-0.60%)
Updated
Sep 25 closing price
Net Assets
8.89B
Interact to see
Advertisement

LADFX vs NRGSX

Header iconLADFX vs NRGSX Comparison
Open Charts LADFX vs NRGSXBanner chart's image
Lord Abbett Developing Growth F
Price$26.85
Change-$0.21 (-0.78%)
VolumeN/A
Net Assets2.07B
Neuberger Berman Genesis R6
Price$63.00
Change-$0.38 (-0.60%)
VolumeN/A
Net Assets8.89B
LADFX vs NRGSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LADFX vs. NRGSX commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LADFX is a Hold and NRGSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NRGSX has more cash in the bank: 8.89B vs. LADFX (2.07B). LADFX pays higher dividends than NRGSX: LADFX (0.12) vs NRGSX (0.06). LADFX was incepted earlier than NRGSX: LADFX (18 years) vs NRGSX (13 years). LADFX (0.79) is less costly to investors than NRGSX (0.74). LADFX is a more actively managed with annual turnover of: 122.00 vs. NRGSX (13.00). LADFX (0) and NRGSX (0) have matching initial minimum investment requirements. LADFX annual gain was more profitable for investors over the last year : 12.89 vs. NRGSX (-6.44). NRGSX return over 5 years is better than : 7.59 vs. LADFX (-1.23).
LADFXNRGSXLADFX / NRGSX
Total Expense Ratio0.790.74107%
Annual Report Gross Expense Ratio0.790.74107%
Fund Existence18 years13 years-
Gain YTD11.266-3.015-374%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets2.07B8.89B23%
Annual Yield % from dividends0.120.06197%
Returns for 1 year12.89-6.44-200%
Returns for 3 years51.5312.25421%
Returns for 5 years-1.237.59-16%
Returns for 10 years29.8217.49171%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MNHIX26.88N/A
N/A
Manning & Napier Pro-Blend Max Term I
BLRAX11.82N/A
N/A
Brookfield Global Listed Real Estate A
PHLQX43.70N/A
N/A
PGIM Jennison Health Sciences R6
RREMX16.54N/A
N/A
RBC Emerging Markets Equity R6
CIQRX13.38N/A
N/A
Segall Bryant & Hamll Intl Eq Retl